{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:07:10Z","timestamp":1789913230933,"version":"4.0.1"},"reference-count":13,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2013]]},"DOI":"10.3960\/jslrt.53.63","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T23:26:52Z","timestamp":1371770812000},"page":"63-68","source":"Crossref","is-referenced-by-count":54,"title":["Thrombocytopenia with Reticulin Fibrosis Accompanied by Fever, Anasarca and Hepatosplenomegaly : A Clinical Report of Five Cases"],"prefix":"10.3960","volume":"53","author":[{"given":"Kazue","family":"Takai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nikkuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Momoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsue","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Kuwana M, Kurata Y, Fujimura K, Fujisawa K, Wada H, <I>et al<\/I>.: Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura : evaluation by multi-center prospective study. J Thromb Haemost 4:1936-1943, 2006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Dogan A, Attygalle AD, Kyriakou C: Angioimmunoblastic T-cell lymphoma. Br J Haematol 121:681-691, 2003","DOI":"10.1046\/j.1365-2141.2003.04335.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Mourad N, Mounier N, Bri&egrave;re J, Raffoux E, Delmer A, <I>et al<\/I>.: Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 111:4463-4470, 2008","DOI":"10.1182\/blood-2007-08-105759"},{"key":"4","unstructured":"4 Takahashi N, Chubachi A, Kume M, Hatano Y, Komatsuda A, <I>et al<\/I>.: A clinical analysis of 52 adult patients with hemophagocytic syndrome : the prognostic significance of the underlying diseases. Int J Hematol 74:209-213, 2001"},{"key":"5","unstructured":"5 Mori S, Mohri N, Uchida T, Shimamine T: Idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia. A syndrome related to giant lymph node hyperplasia of plasma cell type. J Jap Soc RES 20 (Suppl):85-94, 1980 (<I>in Japanese<\/I>)"},{"key":"6","unstructured":"6 Kojima M, Nakamura N, Tsukamoto N, Otuski Y, Shimizu K, <I>et al<\/I>.: Clinical implications of idiopathic multicentric Castleman disease among Japanese : A report of 28 cases. Int J Surg Pathol 16:391-398, 2008"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Dispenzieri A: Castleman disease. Cancer Treat Res 142:293-330, 2008","DOI":"10.1007\/978-0-387-73744-7_13"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, <I>et al<\/I>.: Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 106:2627-2632, 2005","DOI":"10.1182\/blood-2004-12-4602"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Frizzera G, Peterson BA, Bayrd ED, Goldman A: A systemic lymphoproliferative disorder with morphologic features of Castleman's disease : Clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3:1202-1216, 1985","DOI":"10.1200\/JCO.1985.3.9.1202"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Dispenzieri A: How I treat POEMS syndrome. Blood 119:5650-5658, 2012","DOI":"10.1182\/blood-2012-03-378992"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Dispenzieri A: POEMS syndrome : 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 86:591-601, 2011","DOI":"10.1002\/ajh.22050"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Kiss E, Gl I, Simkovics E, Kiss A, Bnyai A, <I>et al<\/I>.: Myelofibrosis in systemic lupus erythematosus. Leuk Lymphoma 39:661-665, 2000","DOI":"10.3109\/10428190009113399"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Paquette RL, Meshkinpour A, Rosen PJ: Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus. Medicine (Baltimore) 73:145-152, 1994","DOI":"10.1097\/00005792-199405000-00003"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:46:37Z","timestamp":1621539997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/53\/1\/53_63\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.53.63","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}